Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Oral bicalutamide is safe and effective for female hair loss.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Certain drugs that block specific enzymes can help treat prostate diseases.

TNF-alpha inhibitors can cause various immune-related skin issues.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Using both bone marrow concentrate and platelet-rich plasma together improves skin wound healing in mice.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Biologics for severe asthma have known side effects, but some new risks need more study.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Tislelizumab can cause cutaneous lupus erythematosus.

Donors on most medications can donate certain blood products without waiting, except for specific drugs that need a waiting period.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

Alitretinoin may help treat alopecia areata.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.